Ginkgo Bioworks Holdings Inc

11 ago 2026, 20:02 UTC

Ginkgo Bioworks shares are lower, tracking the broader market's decline. The stock remains below its 20-day moving average after four consecutive sessions of losses.

10 ago 2026, 19:26 UTC

Ginkgo Bioworks reported second-quarter revenue of $20 million, a 48% decline year-over-year. Shares are trading lower, extending a three-day decline.

7 ago 2026, 22:26 UTC

Ginkgo Bioworks shares decline in after-market hours following TD Cowen's downgrade to Hold and a price target cut to $9.

6 ago 2026, 20:02 UTC

Ginkgo Bioworks is down significantly today, continuing a decline since Wednesday's close, despite recent operational improvements and a brief recovery earlier in the session.

5 ago 2026, 22:51 UTC

Ginkgo Bioworks shares are lower in after-market trading following a revenue miss of $20 million, despite an EPS beat of -$0.92.

4 ago 2026, 19:46 UTC

Ginkgo Bioworks shares are higher today, continuing a four-session rally, supported by broader market trends and easing inflation concerns from falling crude oil prices.

3 ago 2026, 20:04 UTC

Ginkgo Bioworks Holdings Inc. is up notably since Friday's close, reflecting strong performance amid broader market gains, despite a slight pullback earlier in the session.

31 lug 2026, 23:16 UTC

Ginkgo Bioworks shares are lower in after-market hours, reflecting broader market weakness and challenges in the specialty chemicals sector.

29 lug 2026, 19:47 UTC

Ginkgo Bioworks has signed a $2.3 million deal with Thermo Fisher for 11 chips. Shares are declining amid broader market weakness and economic uncertainties.

28 lug 2026, 22:46 UTC

Ginkgo Bioworks Holdings Inc. shares are lower in after-market hours, continuing a downward trend amid broader market weakness ahead of the Federal Reserve's policy meeting.

27 lug 2026, 20:51 UTC

Ginkgo Bioworks shares are higher in after-market hours, supported by broader market trends as European indices, including the DAX, also rise.

24 lug 2026, 19:07 UTC

Ginkgo Bioworks participates in the $400 million Genesis Mission but shares are lower amid broader market declines influenced by falling crude oil prices.

21 lug 2026, 17:36 UTC

Ginkgo Bioworks Holdings Inc. is higher today, recovering from a session low, and has gained since Monday amid a broader market uptrend.